The Melville-based company, a distributor of branded and private-label products for dentist and physician offices, said ...

Henry Schein (HSIC) stock is in focus after the company secured exclusive U.S. distribution rights for CytoChip’s FDA-cleared ...

The Melville, New York-based company’s soon-to-be new CEO succeeds Stanley M. Bergman, who stepped down from the post.

Henry Schein currently has a broad portfolio with over $3bn in corporate and owned brand products and services.

Stanley Bergman has worked at Henry Schein for 45 years, more than 35 of which he spent as CEO, and was due to retire at the ...

The new CEO will succeed Stanley Bergman, who has led the pharmaceuticals and healthcare products distributor for the past 35 ...

Henry Schein has named Federick M. Lowery as its new CEO effective March 2, 2026. He will also join the company’s board of ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Media roundtable sessions: “Conversations with Henry Schein: Exploring the Present and Future of Oral Health” will take place to discuss digitalization in dentistry; Henry Schein will also feature ...

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical ...

Henry Schein appoints Frederick Lowery as CEO, succeeding Stanley Bergman to lead growth and strategic initiatives in dental ...